Cargando…
The effects of safinamide according to gender in Chinese parkinsonian patients
The incidence and prevalence of Parkinson’s disease (PD) is expected to raise dramatically over the next decades. Gender-related differences are not yet widely recognized, particularly regarding the response to dopaminergic medications. To analyse gender differences in the clinical effects of safina...
Autores principales: | Pellecchia, M. T., Picillo, M., Russillo, M. C., Andreozzi, V., Oliveros, C., Cattaneo, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667246/ https://www.ncbi.nlm.nih.gov/pubmed/37996493 http://dx.doi.org/10.1038/s41598-023-48067-8 |
Ejemplares similares
-
Efficacy of Safinamide and Gender Differences During Routine Clinical Practice
por: Pellecchia, Maria T., et al.
Publicado: (2021) -
Sex Differences in Parkinson’s Disease: From Bench to Bedside
por: Russillo, Maria Claudia, et al.
Publicado: (2022) -
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease
por: Cattaneo, Carlo, et al.
Publicado: (2017) -
Population pharmacokinetic and pharmacodynamic analyses of safinamide in subjects with Parkinson's disease
por: Loprete, Luca, et al.
Publicado: (2016) -
The effects of safinamide on dysphagia in Parkinson’s disease
por: Hirano, Makito, et al.
Publicado: (2023)